Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market report explains the definition, types, applications, major countries, and major players of the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Atara Biotherapeutics
Guangzhou Xiangxue Pharmaceutical
Bristol Myers Squibb
CARSGEN Therapeutics?Ltd
Pfizer
Legend Biotech
Kite Pharma
Juno Therapeutics
Novartis
Carina Biotech
Sorrento Therapeutics
By Type:
Allogeneic CAR T-Cells
Autologous CAR T-Cells
By End-User:
Hospital
Diagnostic Center
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Outlook to 2028- Original Forecasts
-
2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market- Recent Developments
-
6.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market News and Developments
-
6.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Deals Landscape
7 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Raw Materials and Cost Structure Analysis
-
7.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Raw Materials
-
7.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Price Trend of Key Raw Materials
-
7.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Suppliers of Raw Materials
-
7.4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Rate of Raw Materials
-
7.5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Cost Structure Analysis
-
7.5.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Raw Materials Analysis
-
7.5.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Labor Cost Analysis
-
7.5.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Manufacturing Expenses Analysis
8 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Import and Export Analysis (Top 10 Countries)
-
8.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Export by Region (Top 10 Countries) (2017-2028)
9 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Outlook by Types and Applications to 2022
-
9.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Allogeneic CAR T-Cells Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Autologous CAR T-Cells Consumption and Growth Rate (2017-2022)
-
9.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diagnostic Center Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis and Outlook till 2022
-
10.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.2.2 Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.2.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.2 UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.3 Spain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.4 Belgium Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.5 France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.6 Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.7 Denmark Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.8 Finland Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.9 Norway Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.10 Sweden Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.11 Poland Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.12 Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.13 Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.2 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.3 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.4 South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.5 Pakistan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.6 Bangladesh Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.7 Indonesia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.8 Thailand Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.9 Singapore Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.10 Malaysia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.11 Philippines Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.12 Vietnam Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.2 Colombia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.3 Chile Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.4 Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.5 Venezuela Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.6 Peru Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.7 Puerto Rico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.8 Ecuador Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.6.2 Kuwait Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.6.3 Oman Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.6.4 Qatar Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.6.5 Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.6.6 United Arab Emirates Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.7.2 South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.7.3 Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.7.4 Algeria Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
-
10.8.2 New Zealand Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)
11 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Competitive Analysis
-
11.1 Atara Biotherapeutics
-
11.1.1 Atara Biotherapeutics Company Details
-
11.1.2 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
11.1.4 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Guangzhou Xiangxue Pharmaceutical
-
11.2.1 Guangzhou Xiangxue Pharmaceutical Company Details
-
11.2.2 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
11.2.4 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Bristol Myers Squibb
-
11.3.1 Bristol Myers Squibb Company Details
-
11.3.2 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
11.3.4 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 CARSGEN Therapeutics?Ltd
-
11.4.1 CARSGEN Therapeutics?Ltd Company Details
-
11.4.2 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
11.4.4 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Pfizer
-
11.5.1 Pfizer Company Details
-
11.5.2 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
11.5.4 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Legend Biotech
-
11.6.1 Legend Biotech Company Details
-
11.6.2 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
11.6.4 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Kite Pharma
-
11.7.1 Kite Pharma Company Details
-
11.7.2 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
11.7.4 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Juno Therapeutics
-
11.8.1 Juno Therapeutics Company Details
-
11.8.2 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
11.8.4 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Novartis
-
11.9.1 Novartis Company Details
-
11.9.2 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
11.9.4 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Carina Biotech
-
11.10.1 Carina Biotech Company Details
-
11.10.2 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
11.10.4 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Sorrento Therapeutics
-
11.11.1 Sorrento Therapeutics Company Details
-
11.11.2 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
11.11.4 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
11.11.5 Recent Research and Development Strategies
12 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Outlook by Types and Applications to 2028
-
12.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Allogeneic CAR T-Cells Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Autologous CAR T-Cells Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Diagnostic Center Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis and Outlook to 2028
-
13.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.2.2 Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.2.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.2 UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.3 Spain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.4 Belgium Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.5 France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.6 Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.7 Denmark Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.8 Finland Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.9 Norway Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.10 Sweden Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.11 Poland Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.12 Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.13 Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.2 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.3 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.4 South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.8 Thailand Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.9 Singapore Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.11 Philippines Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.2 Colombia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.3 Chile Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.4 Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.6 Peru Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6.3 Oman Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6.4 Qatar Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.7.2 South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.7.3 Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.7.4 Algeria Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
-
Figure of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Picture
-
Table Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Allogeneic CAR T-Cells Consumption and Growth Rate (2017-2022)
-
Figure Global Autologous CAR T-Cells Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Center Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Table North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Spain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Belgium Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Denmark Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Finland Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Norway Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Sweden Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Poland Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Thailand Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Singapore Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Philippines Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Colombia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Chile Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Peru Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table GCC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure Bahrain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Oman Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Qatar Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure Nigeria Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Algeria Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Oceania Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Atara Biotherapeutics Company Details
-
Table Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
Table Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
Table Guangzhou Xiangxue Pharmaceutical Company Details
-
Table Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
Table Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
Table Bristol Myers Squibb Company Details
-
Table Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
Table Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
Table CARSGEN Therapeutics?Ltd Company Details
-
Table CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
Table CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
Table Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
Table Legend Biotech Company Details
-
Table Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
Table Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
Table Kite Pharma Company Details
-
Table Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
Table Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
Table Juno Therapeutics Company Details
-
Table Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
Table Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
Table Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
Table Carina Biotech Company Details
-
Table Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
Table Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
Table Sorrento Therapeutics Company Details
-
Table Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Main Business and Markets Served
-
Table Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Portfolio
-
Figure Global Allogeneic CAR T-Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autologous CAR T-Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Table North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
